Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review
Immunohistochemical stains are increasingly used to aid in the diagnosis of malignant melanoma, especially when the differentiation of the tumor is unclear based on examination with hematoxylin and eosin. However, aberrant expression of non-melanocytic markers has been reported in melanomas, which c...
Main Authors: | Elie Saliba, Jag Bhawan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Dermatopathology |
Subjects: | |
Online Access: | https://www.mdpi.com/2296-3529/8/3/40 |
Similar Items
-
PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
by: Valerie Glutsch, et al.
Published: (2022-05-01) -
Polymorphic Malignant Melanoma (PMM) of the Left Helix: Case Report with Clinical-Pathological Correlations
by: Gerardo Cazzato, et al.
Published: (2022-11-01) -
Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
by: Yan Wu, et al.
Published: (2021-08-01) -
Oral malignant melanoma: A rare malignancy
by: L S Vagish Kumar
Published: (2015-01-01) -
Oral malignant melanoma: A case report with review of literature
by: T Manigandan, et al.
Published: (2014-01-01)